The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$7.80

Today's change0.00 0.00%
Updated February 11 12:28 PM EST. Delayed by at least 15 minutes.
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$7.80

Today's change0.00 0.00%
Updated February 11 12:28 PM EST. Delayed by at least 15 minutes.

Aralez Pharmaceuticals Inc closed at $7.80.

Over the last five days, shares have gained 524.00% and are currently 4.88% off of the 52-week high. Shares have outperformed the S&P TSX by 988.72% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.54
Updated February 11 12:28 PM EST. Delayed by at least 15 minutes.

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue9665
Total other revenue--------
Total revenue9665
Gross profit6443
Total cost of revenue3222
Total operating expense10865
Selling / general / administrative4432
Research & development--------
Depreciation / amortization2111
Interest expense (income), net operating--------
Unusual expense (income)01--0
Other operating expenses, total--------
Operating income-1-201
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets------0
Other--------
Income before tax1-9-5-1
Income after tax2-9-5-1
Income tax, total00--0
Net income2-9-5-1
Total adjustments to net income--------
Net income before extra. items2-9-5-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2-9-5-1
Inc. avail. to common incl. extra. items2-9-5-1
Diluted net income2-9-5-1
Dilution adjustment--------
Diluted weighted average shares1251099795
Diluted EPS excluding extraordinary itemsvalue per share0.01-0.08-0.05-0.01
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.01-0.07-0.05-0.01